Literature DB >> 29396743

Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care.

Ya-Chen Tina Shih1, Shelley Fuld Nasso2, S Yousuf Zafar3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29396743      PMCID： PMC5835199          DOI： 10.1007/s40273-018-0613-x

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  18 in total

1.  Characterizing health plan price estimator tools: findings from a national survey.

Authors:  Aparna Higgins; Nicole Brainard; German Veselovskiy
Journal:  Am J Manag Care       Date:  2016-02       Impact factor: 2.229

2.  Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?

Authors:  Bruce E Hillner; Thomas J Smith
Journal:  J Clin Oncol       Date:  2007-02-20       Impact factor: 44.544

3.  Full disclosure--out-of-pocket costs as side effects.

Authors:  Peter A Ubel; Amy P Abernethy; S Yousuf Zafar
Journal:  N Engl J Med       Date:  2013-10-17       Impact factor: 91.245

4.  Delivering high-quality and affordable care throughout the cancer care continuum.

Authors:  Ya-Chen Tina Shih; Patricia A Ganz; Denise Aberle; Amy Abernethy; Justin Bekelman; Otis Brawley; James S Goodwin; Jim C Hu; Deborah Schrag; Jennifer S Temel; Lowell Schnipper
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

5.  A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

Authors:  N I Cherny; R Sullivan; U Dafni; J M Kerst; A Sobrero; C Zielinski; E G E de Vries; M J Piccart
Journal:  Ann Oncol       Date:  2015-05-30       Impact factor: 32.976

Review 6.  A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment.

Authors:  Ya-Chen Tina Shih; Chun-Ru Chien
Journal:  Cancer       Date:  2016-11-28       Impact factor: 6.860

Review 7.  A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can't Pay the Co-Pay.

Authors:  Louisa G Gordon; Katharina M D Merollini; Anthony Lowe; Raymond J Chan
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

8.  Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.

Authors:  Ya-Chen Tina Shih; Ying Xu; Lei Liu; Fabrice Smieliauskas
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

9.  Financial toxicity, Part I: a new name for a growing problem.

Authors:  S Yousuf Zafar; Amy P Abernethy
Journal:  Oncology (Williston Park)       Date:  2013-02       Impact factor: 2.990

10.  The utility of cost discussions between patients with cancer and oncologists.

Authors:  S Yousuf Zafar; Fumiko Chino; Peter A Ubel; Christel Rushing; Gregory Samsa; Ivy Altomare; Jonathan Nicolla; Deborah Schrag; James A Tulsky; Amy P Abernethy; Jeffery M Peppercorn
Journal:  Am J Manag Care       Date:  2015-09       Impact factor: 2.229
View more
  10 in total

Review 1.  Understanding Financial Hardship Among Cancer Survivors in the United States: Strategies for Prevention and Mitigation.

Authors:  K Robin Yabroff; Cathy Bradley; Ya-Chen Tina Shih
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

2.  Financial burden amongst cancer patients treated with curative intent surgery alone.

Authors:  Natalie Allcott; Lisette Dunham; David Levy; Jacquelyn Carr; Karyn Stitzenberg
Journal:  Am J Surg       Date:  2019-01-31       Impact factor: 2.565

Review 3.  Where advocacy meets patient-centered care-cost considerations in breast reconstruction decision-making.

Authors:  Whitney Lane; Brett T Phillips; Anaeze C Offodile
Journal:  Gland Surg       Date:  2021-01

4.  Cancer-Related Care Costs and Employment Disruption: Recommendations to Reduce Patient Economic Burden as Part of Cancer Care Delivery.

Authors:  Janet S de Moor; Courtney P Williams; Victoria S Blinder
Journal:  J Natl Cancer Inst Monogr       Date:  2022-07-05

5.  Financial Hardship in Survivorship Care Delivery.

Authors:  Grace L Smith; Tito R Mendoza; Lisa M Lowenstein; Ya-Chen Tina Shih
Journal:  J Natl Cancer Inst Monogr       Date:  2021-09-03

6.  Communication research at the National Cancer Institute, 2013-2019: a grant portfolio analysis.

Authors:  Anna Gaysynsky; Camella J Rising; Neha Trivedi; Kelly D Blake; Wen-Ying Sylvia Chou; April Oh; Robin C Vanderpool
Journal:  Cancer Causes Control       Date:  2021-07-27       Impact factor: 2.506

7.  Protocol for studying the efficiency of ChemoCalc software in helping patients to understand drug treatment costs for breast cancer: A multicenter, open-label, randomized phase 2 study.

Authors:  Sayaka Kuba; Hiroki Moriuchi; Kosho Yamanouchi; Kenichiro Shibata; Hiroshi Yano; Masahiro Oikawa; Shigeto Maeda; Xiangyue Meng; Michi Morita; Toshiko Hatachi; Ryota Otsubo; Megumi Matsumoto; Junya Miyamoto; Kengo Kanetaka; Hideki Taniguchi; Takeshi Nagayasu; Susumu Eguchi
Journal:  Contemp Clin Trials Commun       Date:  2021-02-11

8.  BITES study: A qualitative analysis among emergency medicine physicians on snake envenomation management practices.

Authors:  Anna Tupetz; Loren K Barcenas; Ashley J Phillips; Joao Ricardo Nickenig Vissoci; Charles J Gerardo
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

9.  Delivery of Financial Navigation Services Within National Cancer Institute-Designated Cancer Centers.

Authors:  Janet S de Moor; Michelle Mollica; Annie Sampson; Brenda Adjei; Sallie J Weaver; Ann M Geiger; Barnett S Kramer; Emily Grenen; Memi Miscally; Henry P Ciolino
Journal:  JNCI Cancer Spectr       Date:  2021-04-09

10.  Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market.

Authors:  Ya-Chen Tina Shih; Ying Xu; Hui Zhao; Deborah Schrag; James Yao
Journal:  JNCI Cancer Spectr       Date:  2021-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.